MX2007007427A - Composicion que comprende adapaleno solubilizado con ciclodextrinas. - Google Patents

Composicion que comprende adapaleno solubilizado con ciclodextrinas.

Info

Publication number
MX2007007427A
MX2007007427A MX2007007427A MX2007007427A MX2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A
Authority
MX
Mexico
Prior art keywords
adapalene
cyclodextrins
solubilized
composition
dermatology
Prior art date
Application number
MX2007007427A
Other languages
English (en)
Inventor
Claire Mallard
Sandrine Orsoni
Laurent Fredon
Agnes Ferrandis
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2007007427A publication Critical patent/MX2007007427A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a una composicion que comprende adapaleno solubilizado en un medio acuoso con ciclodextrinas o derivados de las mismas, a su procedimiento de preparacion y a su utilizacion en cosmetica y dermatologia.
MX2007007427A 2004-12-22 2005-12-16 Composicion que comprende adapaleno solubilizado con ciclodextrinas. MX2007007427A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0413760A FR2879459B1 (fr) 2004-12-22 2004-12-22 Composition comprenant de l'adapalene solubilise avec des cyclodextrines
PCT/FR2005/003173 WO2006070093A1 (fr) 2004-12-22 2005-12-16 Composition comprenant de i'adapalene solubilise avec des cyclodextrines

Publications (1)

Publication Number Publication Date
MX2007007427A true MX2007007427A (es) 2008-01-14

Family

ID=34951824

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007427A MX2007007427A (es) 2004-12-22 2005-12-16 Composicion que comprende adapaleno solubilizado con ciclodextrinas.

Country Status (12)

Country Link
US (1) US20080008727A1 (es)
EP (1) EP1830795A1 (es)
JP (1) JP2008525385A (es)
KR (1) KR20070090205A (es)
CN (1) CN101087581A (es)
AU (1) AU2005321158A1 (es)
BR (1) BRPI0517495A (es)
CA (1) CA2591294A1 (es)
FR (1) FR2879459B1 (es)
MX (1) MX2007007427A (es)
RU (1) RU2007127992A (es)
WO (1) WO2006070093A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5125122B2 (ja) * 2007-01-31 2013-01-23 大正製薬株式会社 アダパレン含有外用剤組成物
JP5233149B2 (ja) * 2007-03-31 2013-07-10 大正製薬株式会社 アダパレン含有外用剤組成物
JP5061984B2 (ja) * 2007-03-31 2012-10-31 大正製薬株式会社 アダパレン含有外用剤組成物
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2944207B1 (fr) 2009-04-09 2011-05-06 Galderma Res & Dev Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations
FR2944280B1 (fr) * 2009-04-09 2012-08-03 Galderma Res & Dev Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines
US8802653B2 (en) * 2010-10-01 2014-08-12 C.B. Fleet Company, Inc. Deodorant compositions
US8685380B2 (en) 2010-10-25 2014-04-01 C.B. Fleet Company, Inc. Deodorant spray
WO2014159659A1 (en) * 2013-03-12 2014-10-02 Stein Emily A Dental composition comprising chelator and base
FR3018192B1 (fr) * 2014-03-06 2017-09-01 Laboratoires M&L Composition cosmetique comprenant de la gomme de sclerotium (sclerotium gum)
EP3475312B1 (en) 2016-06-23 2020-05-27 Galderma S.A. Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
CN113577013B (zh) * 2020-10-23 2023-12-22 南京欣通瑞亿医药科技有限公司 一种含有氨苯砜类化合物的经皮给药组合物及其制备方法
KR102608639B1 (ko) * 2021-01-27 2023-12-01 주식회사 티엠에스헬스케어 캡슐화케라틴의 제조방법 및 이의 방법으로 제조된 캡술화케라틴을 포함하는 피부장벽 개선용 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
AU5132799A (en) * 1998-07-28 2000-02-21 Bershad, Susan Short contact treatment of acne and photoaging with topical retinoids
US6048902A (en) * 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
US6322801B1 (en) * 1999-08-02 2001-11-27 The Procter & Gamble Company Personal care articles
JP2005526063A (ja) * 2002-03-12 2005-09-02 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ 皮膚疾患を治療するためのアダパレンの使用
EP1449514A1 (de) * 2003-02-13 2004-08-25 Beiersdorf AG Hautpflegeprodukte mit Retinoiden, Ubichinonen sowie Biotin oder Carnitin

Also Published As

Publication number Publication date
CN101087581A (zh) 2007-12-12
RU2007127992A (ru) 2009-01-27
US20080008727A1 (en) 2008-01-10
BRPI0517495A (pt) 2008-10-07
FR2879459A1 (fr) 2006-06-23
JP2008525385A (ja) 2008-07-17
WO2006070093A1 (fr) 2006-07-06
KR20070090205A (ko) 2007-09-05
EP1830795A1 (fr) 2007-09-12
CA2591294A1 (fr) 2006-07-06
FR2879459B1 (fr) 2007-02-16
AU2005321158A1 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
MX2007007427A (es) Composicion que comprende adapaleno solubilizado con ciclodextrinas.
WO2006069998A3 (de) Glycopyrrolat in kosmetischen zubereitungen
MX272846B (es) Dispersion acuosa, metodo de produccion y su uso.
WO2007041584A3 (en) Implantable sensors, implantable pumps, and anti-scarring drug combinations
WO2008039341A3 (en) Sterilizing cutting system
WO2010002586A3 (en) Topical compositions comprising isonicotinamide
AU303542S (en) Metal extrusion for tilework
WO2006072015A3 (en) Organometallic complexes
ZA200700680B (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
WO2004021967A3 (en) Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
IL176513A0 (en) Diarylmethyl piperazine derivatives, preparations thereof and used thereof
WO2006120133A3 (en) Process for coloring keratin fibers comprising metal complexes
MXPA06002882A (es) Dispersiones de adhesivo acuosas.
MX2009003060A (es) Emulsion.
AU2003276081A1 (en) Aqueous polymer dispersions containing alkyldiketenes, methods for the production thereof, and their use
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
CA105215S (en) Packaging with cosmetic composition
AU2001273999A1 (en) Fluorescein isothiocyanate (fitc) sinistrin, its production and use
WO2006134279A3 (fr) Procede de solubilisation du metronidazole a l’aide de niacinamide et de deux glycols, solution ainsi obtenue
WO2006116076A3 (en) Tab molecules
GB0525944D0 (en) Water-soluble isoflavone composition, process for producing the same, and use thereof
MXPA03001557A (es) Derivados bifenilo.
MY139010A (en) 6-azo-5, 5'-dihydroxy -7,7'-disulfo-2-2'-dinaphthylamine derivatives
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
IL188185A0 (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
FA Abandonment or withdrawal